Back to Search
Start Over
Biocon accused of committing IP theft to create cancer biotech Bicara.
- Source :
- FierceBiotech; 10/24/2024, pN.PAG-N.PAG, 1p
- Publication Year :
- 2024
-
Abstract
- Shortly after Bicara Therapeutics raised more than $360 million in an IPO, the cancer biotech and its former parent company have been hit with accusations of intellectual property theft. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- Database :
- Complementary Index
- Journal :
- FierceBiotech
- Publication Type :
- Periodical
- Accession number :
- 180503527